Basic Information
Basic information for MKLN1-AS-210-16aa
Peptide Name MKLN1-AS-210-16aa
Genome Position chr7:131323629-131323676[-]
Species Human
Peptide Sequence MIYGVLSCSIWESRPI
Peptide Length 16
Unique No (MKLN1-AS-201-16aa,MKLN1-AS-202-16aa,MKLN1-AS-203-16aa,MKLN1-AS-205-16aa-2,MKLN1-AS-206-16aa,MKLN1-AS-207-16aa-2,MKLN1-AS-208-16aa-1,MKLN1-AS-209-16aa,MKLN1-AS-211-16aa-1,MKLN1-AS-212-16aa-1,MKLN1-AS-213-16aa,MKLN1-AS-214-16aa,MKLN1-AS-215-16aa,MKLN1-AS-216-16aa)
Grand Average of Hydropathicity 0.7062
Relative Molecular Mass 2124.41
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236753;MKLN1-AS
Transcript ID/Name ENST00000655177;MKLN1-AS-210
Transcript Length 2191
Coding Ability 0.2656
DNA Sequence Corresponding to Peptide ATGATTTATGGGGTACTGTCTTGTAGTATCTGGGAAAGTAGACCCATC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :